市場調查報告書
商品編碼
1466085
智慧醫療產品市場:按產品類型、應用、分佈、最終用戶分類 - 全球預測 2024-2030Smart Healthcare Products Market by Product Type (Electronic Health Record, mHealth, Smart Pills), Application (Health Data Storage and Exchange, Inventory Management, Monitoring and Treatment), Distribution, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年智慧醫療產品市場規模為76.9億美元,預計2024年將達89.2億美元,2030年將達到219.1億美元,複合年成長率為16.11%。
智慧醫療保健產品市場包括各種旨在改善患者照護、簡化醫療保健服務和最佳化醫療保健提供者業務成果的產品。該市場包括穿戴式裝置、電子健康記錄、智慧藥丸、遠端醫療解決方案等。智慧醫療產品的應用涵蓋了健康管理的各個方面,包括診斷、監測、治療、健康教育、健康預防等。最終用戶範圍從醫院和診所到尋求個人健康管理解決方案的個人消費者。這種多樣化的應用基礎凸顯了這個市場的廣度。推動智慧醫療產品市場擴張的關鍵因素是慢性病盛行率上升、人口老化、慢性病盛行率上升、智慧型手機普及上升以及個人化和高效的醫療保健解決方案的需求。然而,智慧醫療產品也存在一些局限性,例如高成本、資料隱私和安全問題以及缺乏跨平台和設備的標準化。監管挑戰和某些地區技術採用緩慢也阻礙了成長。同時,政府加強對醫療基礎設施數位化的支持,引進先進和創新的智慧醫療產品,創建可無縫整合到現有醫療保健系統的互通性和擴充性的解決方案,提供即時健康監測和服務。
主要市場統計 | |
---|---|
基準年[2023] | 76.9億美元 |
預測年份 [2024] | 89.2億美元 |
預測年份 [2030] | 219.1億美元 |
複合年成長率(%) | 16.11% |
產品類型 人們越來越偏好用於個人健康追蹤的行動醫療(行動醫療 ) 產品
電子健康記錄(EHR) 系統是病患紙本病歷的數位版本,可以即時存取。 EHR 記錄患者的病歷、診斷、治療計劃、藥物、疫苗接種日期、過敏、放射影像、實驗室檢查結果等。電子病歷受到醫療保健提供者的青睞,因為它們可以實現高效、無錯誤的記錄並輕鬆存取患者資料,從而促進更好的決策。行動醫療(行動醫療) 涉及使用行動裝置追蹤健康參數、疾病管理和獲取醫療保健服務。 行動醫療非常適合需要持續監測的患者、具有健康意識的患者以及需要遠端醫療醫療諮詢的患者。智慧藥丸是帶有電子元件的可攝入膠囊,可監測健康指標或以受控方式輸送藥物。適合需要嚴格用藥依從性或正在接受需要密切監測的複雜治療的患者。智慧 RFID 櫃用於安全儲存和管理醫療機構中的藥品和用品,自動追蹤存量基準和使用情況。對於需要簡化庫存管理、減少竊盜並確保藥品安全的醫院和藥局至關重要。智慧注射器旨在防止重複使用,使用一次後自動停用,並採用針頭縮回技術以避免針刺傷害。它們對於防止醫療機構中因共用針頭和意外針刺而導致的感染疾病傳播具有重要意義。遠端醫療允許患者透過數位平台遠端接受醫療服務,包括視訊通話。遠端醫療對於偏遠或服務欠缺地區的患者、行動不便的患者以及希望方便地獲得專科護理的個人來說是有益的。智慧醫療產品市場多元化,每個細分市場都滿足獨特的醫療需求。電子病歷和遠端醫療的重點是資料存取和遠端醫療提供,這在大流行期間和之後都至關重要。行動醫療提供個人健康追蹤,智慧藥丸和智慧注射器專注於藥物和治療的準確性。
最終用戶:醫院擴大智慧醫療產品的使用,以改善病患的治療效果
醫院是智慧醫療產品的主要用戶,專注於改善患者治療結果、簡化業務並做出資料主導的決策。受歡迎的醫院產品包括人工智慧診斷和治療系統、電子健康記錄(EHR)、智慧床和病患監護系統。醫院在這些創新中尋求的重點是互通性、擴充性以及與現有醫院管理系統整合的能力。門診護理病房 (ACU) 擴大採用智慧醫療產品,以提高患者照護和業務效率。在此類病房中,由於空間和移動性要求有限,因此首選緊湊、攜帶式且易於使用的設備。 ACU 對遠端醫療平台、可攜式監測設備和穿戴式健康設備的需求很高,以促進遠端患者監護和即時健康追蹤。在居家照護環境中,人們越來越偏好智慧醫療保健產品來支持居家照護和管理慢性病。促進遠端健康監測、藥物管理和緊急通知系統的設備尤其受到青睞。該細分市場的消費者優先考慮易用性、可靠性以及與其他智慧家庭設備整合的能力。在比較 ACU、家庭護理環境和醫院中智慧醫療產品的使用情況時,出現了幾個重要的差異。在 ACU 和家庭護理環境中,攜帶性和易用性是首要考慮因素,重點是遠端監控功能,以支援傳統臨床環境之外的患者。相反,醫院正在強調先進的互通性、資料分析和人工智慧主導的技術,以更大規模地提高患者照護和醫院效率。
區域洞察
在美國和加拿大,人們越來越重視醫療保健效率和以病人為中心的照護。物聯網 (IoT) 在健康設備中的整合、人工智慧 (AI) 以及主要市場參與者的存在正在對消費者的需求和購買產生重大影響。慢性病管理和遠端患者監護是高度優先領域,導致智慧健康穿戴式裝置和遠端醫療解決方案的採用。由於人們對數位醫療技術和遠端醫療優勢的了解不斷加深,南美地區,尤其是巴西等國家,智慧醫療產品的採用率不斷增加。歐洲、中東和非洲地區情況各異,客戶需求和購買行為各不相同。在歐盟國家,重點是數位健康整合,以遵循通用資料保護規範 (GDPR) 等法律規範,在數位健康解決方案中提供資料隱私。中東地區人口年輕,在大量投資和政府支持下熱衷於採用創新醫療技術。儘管基礎設施存在挑戰,但行動醫療解決方案在非洲仍有潛力,這主要是由於行動普及較高,而且消費者的需求旨在解決醫療服務問題和管理感染疾病。由於亞太地區龐大的人口基數、可支配收入的增加以及對電子醫療潛力的認知不斷增強,預計亞太地區將成為智慧醫療產品的高成長市場。擁有先進技術行業的日本和擁有大型製造業並正在醫療保健領域實施數位技術的中國等國家為這一成長做出了重大貢獻。印度市場正在快速成長,在數位印度計畫等措施的推動下,重點關注負擔得起且易於獲得的醫療保健解決方案。
FPNV定位矩陣
FPNV定位矩陣對於評估智慧醫療產品市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一個綜合工具,可以對智慧醫療產品市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 智慧醫療市場規模及預測如何?
2.智慧醫療產品市場預測期間有哪些產品、細分市場、應用和領域值得考慮投資?
3. 智慧醫療市場的技術趨勢和法規結構是什麼?
4.智慧醫療市場主要廠商的市場佔有率如何?
5. 進入智慧醫療市場的合適型態和策略手段是什麼?
[189 Pages Report] The Smart Healthcare Products Market size was estimated at USD 7.69 billion in 2023 and expected to reach USD 8.92 billion in 2024, at a CAGR 16.11% to reach USD 21.91 billion by 2030.
The smart healthcare products market encompasses a range of products designed to improve patient care, enhance the efficiency of healthcare delivery, and optimize operational outcomes for healthcare providers. This market includes wearable devices, electronic health records, smart pills, and telemedicine solutions. Applications of smart healthcare products span various aspects of health management, including diagnosis, monitoring, treatment, health education, and wellness prevention. End-users cover a broad spectrum ranging from hospitals and clinics to individual consumers seeking personal health management solutions. This diverse application base highlights the market's expansive scope. The primary factors for the expansion of the smart healthcare products market include the rising prevalence of chronic diseases, aging populations, growing incidences of chronic diseases, higher penetration of smartphones, and the demand for personalized and efficient healthcare solutions. However, the market faces limitations such as high costs associated with smart healthcare products, data privacy and security problems, and a lack of standardization across platforms and devices. Regulatory challenges and the slow pace of technology adoption in certain regions also impede growth. On the other hand, growing government support for the digitization of healthcare infrastructure, introduction of advanced and innovative smart healthcare products, development of interoperable and scalable solutions that can seamlessly integrate into existing healthcare systems, providing real-time health monitoring and data analytics for predictive diagnostics and personalized treatment plans and focusing on innovations in data analytics, AI, and patient-centric models presents potential opportunities for the market to grow in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.69 billion |
Estimated Year [2024] | USD 8.92 billion |
Forecast Year [2030] | USD 21.91 billion |
CAGR (%) | 16.11% |
Product Type: Increasing preference for mobile health (mHealth) products for personal health tracking
Electronic health record (EHR) systems are digital versions of patients' paper charts, accessible in real time. They contain the medical history, diagnoses, treatment plans, medications, immunization dates, allergies, radiology images, and laboratory test results of patients. EHR is preferred by healthcare providers for efficient, error-free documentation and easy access to patient data, facilitating better decision-making. Mobile health (mHealth) involves using mobile devices to track health parameters, manage diseases, and access healthcare services. This includes health monitoring apps, wellness apps, and medical consultation apps. mHealth is ideal for patients needing continuous monitoring, health-conscious individuals, and those requiring remote medical consultations. Smart pills are ingestible capsules equipped with electronic components to monitor health metrics or deliver drugs in a controlled manner. It is suitable for patients requiring stringent medication adherence and those undergoing complex treatments requiring close monitoring. Smart RFID cabinets are used to store and manage medications and supplies securely in healthcare facilities, automatically tracking inventory levels and usage. It is essential for hospitals and pharmacies needing to streamline inventory management, reduce theft, and ensure medication safety. Smart syringes are designed to prevent reuse, automatically disable after a single use, or feature needle retraction technology to avoid needlestick injuries. It is precious in preventing the spread of infectious diseases through needle sharing and accidental needlestick injuries in healthcare settings. Telemedicine allows patients to acquire healthcare services remotely through digital platforms, including video calls, enabling access to consultants and specialists without needing physical travel. Telemedicine is beneficial for patients in remote or underserved locations, those with mobility issues, or individuals seeking convenient access to specialist care. The smart healthcare products market is diverse, each segment addressing unique health needs. EHR and telemedicine emphasize data access and remote healthcare delivery, which are essential during and after the post-pandemic. mHealth offers personal health tracking, while smart pills and smart syringes focus on medication and treatment precision.
End-User: Expanding usage of smart healthcare products by hospitals to improve patient outcomes
Hospitals are prime users of smart healthcare products, focusing on improving patient outcomes, operational efficiency, and data-driven decision-making. High-demand hospital products include AI-enabled diagnostic and treatment systems, electronic health records (EHRs), smart beds, and patient monitoring systems. The key aspects hospitals look for in these innovations are interoperability, scalability, and the ability to integrate with existing hospital management systems. Ambulatory care units (ACUs) increasingly incorporate smart healthcare products to enhance patient care and operational efficiency. These units prefer compact, portable, and easy-to-use devices, given their often limited space and the need for mobility. Telehealth platforms, portable monitoring devices, and wearable health devices are in high demand in ACUs to facilitate remote patient monitoring and real-time health tracking. In-home care settings, there is a growing preference for smart healthcare products that support aging in place and manage chronic conditions. Devices that facilitate remote health monitoring, medication management, and emergency alert systems are particularly favored. Consumers in this segment prioritize ease of use, reliability, and integration capabilities with other smart home devices. When comparing the usage of smart healthcare products among ACUs, home care settings, and hospitals, several key differences emerge. ACUs and home care settings prioritize portability and ease of use, with a significant focus on remote monitoring capabilities to support patients outside traditional clinical environments. Conversely, hospitals emphasize sophisticated interoperability, data analytics, and AI-driven technologies to enhance patient care and hospital efficiency on a larger scale.
Regional Insights
In the United States and Canada, there is an increasing emphasis on healthcare efficiency and patient-centered care. The integration of the Internet of Things (IoT) in health devices, Artificial Intelligence (AI), and the presence of key market players have greatly influenced consumer needs and purchases. Chronic disease management and remote patient monitoring are high-priority areas, leading to the adoption of smart health wearables and telehealth solutions. South America is experiencing a rising adoption of smart healthcare products, especially in countries including Brazil, driven by an increasing understanding of the advantages of digital health technologies and telemedicine. With a heterogeneous landscape, the EMEA region presents diverse customer needs and purchasing behaviors. In EU countries, the focus is on digital health integration following regulatory frameworks, including the General Data Protection Regulation (GDPR), providing data privacy in digital health solutions. The Middle East, with a younger population, is keen on adopting innovative health technologies boosted by significant investments and government support. In Africa, despite infrastructural challenges, there is potential for mHealth solutions, mainly due to the high mobile penetration, and consumer needs are geared towards addressing health access issues and managing infectious diseases. The APAC region is expected to be a high-growth market for smart healthcare products due to the vast population base, rising disposable incomes, and increasing awareness of the potential of eHealth. Countries such as Japan, with its advanced technology sector, and China, with its large-scale manufacturing and adoption of digital technologies in healthcare, contribute significantly to this growth. India's market is burgeoning, focusing on affordable and accessible healthcare solutions facilitated by initiatives, including the Digital India program.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Smart Healthcare Products Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Smart Healthcare Products Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Smart Healthcare Products Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AirStrip Technologies, Inc., Allscripts Healthcare Solutions, Inc., American Well Corporation, Apple Inc., AT&T Inc., Becton, Dickinson and Company, CapsoVision, Inc., Cisco Systems Inc., eClinicalWorks, Epic Systems Corporation, General Electric Company, Gerresheimer AG, Honeywell International Inc., International Business Machines Corporation, Koninklijke Philips N.V., LifeSense Group, Logi-Tag Systems Ltd., McKesson Corporation, Medtronic PLC, Olympus Corporation, Oracle Corporation, Resideo Technologies, Inc., Samsung Electronics Co., Ltd., Securitas Healthcare LLC, Siemens AG, and Terumo Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Smart Healthcare Products Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Smart Healthcare Products Market?
3. What are the technology trends and regulatory frameworks in the Smart Healthcare Products Market?
4. What is the market share of the leading vendors in the Smart Healthcare Products Market?
5. Which modes and strategic moves are suitable for entering the Smart Healthcare Products Market?